CVS replaces CEO Karen Lynch with exec David Joyner as income, share value endure

Longtime CVS Well being government David Joyner has changed Karen Lynch as CEO, as the corporate struggles to drive increased income and inventory efficiency, CVS introduced Friday.

The transfer, efficient Thursday, the day earlier than the announcement, comes as CVS shares have fallen almost 20% this yr. Shares plunged about 11% in premarket buying and selling Friday.

CVS has confronted challenges as increased medical prices weigh on its insurance coverage unit, Aetna, and shopper spending drops at its retail pharmacies. In August, the corporate slashed its full-year revenue steerage and stated it could lower $2 billion in prices over the following a number of years.

In its launch Friday, CVS additionally stated it expects adjusted earnings of between $1.05 and $1.10 per share in its third quarter. It anticipates increased medical prices than beforehand anticipated, with a so-called medical profit ratio of 95.2% within the quarter.

“In mild of continued elevated medical value pressures within the Well being Care Advantages section, buyers ought to now not depend on the Firm’s earlier steerage supplied on its second quarter 2024 earnings name on August 7, 2024,” CVS stated within the launch.

The corporate is ready to report third-quarter earnings on Nov. 6.

Final month, main CVS shareholder Glenview Capital started a big push for modifications on the firm, CNBC beforehand reported.

CNBC reported final month that CVS’ board had engaged strategic advisors to weigh its choices, together with the potential of a breakup of its insurance coverage and retail companies.

Joyner most lately oversaw the corporate’s pharmacy companies enterprise as president of CVS Caremark, the same place to the one Lynch held earlier than she assumed the highest job in February 2021. He started his profession at Aetna in pharmacy profit companies and beforehand held the function of government vice chairman of gross sales and advertising and marketing at CVS Well being.

“We consider David and his deep understanding of our built-in enterprise may also help us extra immediately tackle the challenges our trade faces, extra quickly advance the operational enhancements our firm requires, and absolutely notice the worth we will uniquely create,” Chairman Roger Farah stated in a press release.

Lynch additionally stepped down from the corporate’s board of administrators this week, the corporate stated Friday. Joyner will sit on the board, and Farah will assume the function of government chairman.

That is breaking information. Please refresh for updates.